Active ingredientTriclabendazoleCat. No. P-T197-001CAS 68786-66-3Family · Pharmaceutical analytical standards
Triclabendazole
A benzimidazole anthelmintic, long used in veterinary medicine too, that treats fascioliasis and paragonimiasis in humans, infections by flatworms of the liver and lungs; in the United States it was approved for human use in 2019. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It is an unusual benzimidazole: it has a chlorinated benzene ring and, unlike its relatives, no carbamate group; it is on the WHO List of Essential Medicines.
Go to the active ingredient →Active ingredientTriclabendazoleCat. No. P-T197-001CAS 68786-66-3
Pharmacopoeial impurityTriclabendazole EP Impurity ACat. No. P-T197-002CAS 100648-13-3
Pharmacopoeial impurityTriclabendazole EP Impurity BCat. No. P-T197-003CAS 68828-69-3
Isotopically labelledTriclabendazole EP Impurity A-13C-d3Cat. No. P-T197-004
Isotopically labelledTriclabendazole-13C-d3Cat. No. P-T197-006CAS 2938916-53-9
ImpurityKetotriclabendazoleCat. No. P-T197-007CAS 1201920-88-8
ImpurityAmino Triclabendazole HClCat. No. P-T197-008
ImpurityHydroxy TriclabendazoleCat. No. P-T197-009CAS 109536-21-2
ImpurityN1-MethyltriclabendazoleCat. No. P-T197-010CAS 145770-88-3
ImpurityN3-MethyltriclabendazoleCat. No. P-T197-011CAS 145770-89-4
ImpurityTriclabendazole SulfoneCat. No. P-T197-012CAS 106791-37-1No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceTriclabendazole CRSEDQM code Y0001737Family TriclabendazoleNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.